Scarica l'app Stockscreener
12.85
81.24%
5.76
Dopo l'orario di chiusura:
11.96
-0.89
-6.93%
Precedente Chiudi:
$7.09
Aprire:
$9.17
Volume 24 ore:
21.09M
Relative Volume:
33.93
Capitalizzazione di mercato:
$217.89M
Reddito:
$53.74M
Utile/perdita netta:
$33.24M
Rapporto P/E:
4.825
EPS:
2.6632
Flusso di cassa netto:
$-27.40M
1 W Prestazione:
+126.63%
1M Prestazione:
+134.92%
6M Prestazione:
+523.79%
1 anno Prestazione:
+664.88%
Intervallo 1D:
$9.15
$13.15
Intervallo di 1 settimana:
$5.375
$13.15
Portata 52W:
$1.345
$13.15
Q 32 Bio Inc Stock (QTTB) Company Profile
Nome
Q 32 Bio Inc
Settore
Industria
Telefono
781-999-0232
Indirizzo
830 WINTER STREET, WALTHAM
Compare QTTB vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
QTTB
Q 32 Bio Inc
|
12.85 | 120.22M | 53.74M | 33.24M | -27.40M | 2.6632 |
VRTX
Vertex Pharmaceuticals Inc
|
437.22 | 110.64B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
627.74 | 66.53B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
820.63 | 50.27B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.63 | 39.45B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
153.00 | 32.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Q 32 Bio Inc Stock (QTTB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-25 | Iniziato | H.C. Wainwright | Buy |
| 2025-02-11 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2025-02-11 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-12-11 | Downgrade | Guggenheim | Buy → Neutral |
| 2024-12-11 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-12-11 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2024-12-11 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | Iniziato | BMO Capital Markets | Outperform |
| 2024-10-24 | Iniziato | Raymond James | Strong Buy |
| 2024-09-11 | Iniziato | Wells Fargo | Overweight |
| 2024-06-17 | Iniziato | Guggenheim | Buy |
| 2024-05-21 | Iniziato | Leerink Partners | Outperform |
| 2024-04-11 | Iniziato | Oppenheimer | Outperform |
| 2024-04-02 | Iniziato | Piper Sandler | Overweight |
| 2023-07-28 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-02-22 | Reiterato | BTIG Research | Neutral |
| 2022-02-22 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-02-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-03-02 | Iniziato | Stifel | Hold |
| 2020-12-14 | Ripresa | H.C. Wainwright | Buy |
| 2020-08-11 | Reiterato | H.C. Wainwright | Buy |
| 2020-06-25 | Ripresa | BofA/Merrill | Buy |
| 2020-05-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2020-03-16 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2020-02-24 | Iniziato | Chardan Capital Markets | Buy |
| 2019-11-01 | Iniziato | Oppenheimer | Perform |
| 2019-09-10 | Iniziato | Robert W. Baird | Outperform |
| 2019-04-12 | Iniziato | Evercore ISI | Outperform |
Mostra tutto
Q 32 Bio Inc Borsa (QTTB) Ultime notizie
Q32 Bio Inc. (QTTB) Stock: Surges After $55 Million Private Placement Led by Top Biotech Investors - parameter.io
Q32 Bio Secures $55 Million Private Placement to Advance Alopecia Areata Pipeline (QTTB) - Yahoo Finance
Q32 Bio Inc. announced that it expects to receive $53.8 million in funding from Atlas Venture Advisors, Inc., OrbiMed Advisors LLC, BVF Partners L.P., RA Capital Management, L.P. - marketscreener.com
Q32 Bio announces $55M private placement - MSN
Q32 Bio Inc. (QTTB) Secures $55M in Private Placement of Common Stock - GuruFocus
Q32 Bio announces $55 million private placement financing - marketscreener.com
Q32 Bio Announces $55 Million Private Placement Financing - PR Newswire
This Q32 Bio analyst begins coverage on a bullish note; here are top 3 initiations for Friday - MSN
This Q32 Bio Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday - Benzinga
Mizuho initiates Q32 Bio stock coverage with Outperform rating - Investing.com UK
QTTB | Q32 Bio Inc. Common Analyst Forecasts - Quiver Quantitative
Mizuho initiates Q32 Bio stock coverage with Outperform rating By Investing.com - Investing.com Australia
Q32 BIO INC. (QTTB) - MSN
Q32 Bio gears up to report Q1 earnings: What's in the cards? - MSN
Point72 reports 958,768-share (5.7%) stake in Q32 Bio (QTTB) - Stock Titan
Sirenia and Alex Silverstein report 9.9% stake in Q32 Bio (QTTB) - Stock Titan
Q32 Bio (QTTB) Stock Price, News & Analysis - MarketBeat
Number of shareholders of Q32 Bio Inc. – NASDAQ:QTTB - TradingView
Number of shareholders of Q32 Bio Inc. – BOATS:QTTB - TradingView
The organic vs inorganic growth story at Q32 Bio (QTTB) | Q4 2025: EPS Beats ForecastsReal-time Trade Ideas - newser.com
QTTB SEC FilingsQ32 BIO INC 10-K, 10-Q, 8-K Forms - Stock Titan
QTTB Q32 Bio posts massive EPS beat, yet shares dip despite blowout quarter.Working Capital - newser.com
Wall Street Analysts Believe Q32 Bio (QTTB) Could Rally 163.42%: Here's is How to Trade - Yahoo Finance Singapore
How Q32 Bio (QTTB) guidance shapes future expectations | Q4 2025: Profit SurprisesBest Pick - newser.com
Why Q32 Bio (QTTB) might be the portfolio Builder you need (+6.42%) 2026-05-06Fundamentals - newser.com
OrbiMed updates Q32 Bio (QTTB) ownership at 13.3% of common stock - Stock Titan
Opaleye/James Silverman hold 8.59% of Q32 Bio (NASDAQ: QTTB) - Stock Titan
Q32 Bio Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Q32 Bio: Q1 Earnings Snapshot - theheraldreview.com
Regulatory Compliance Risks: Q32 Bio Warns of Internal Control Challenges Under Sarbanes-Oxley and Potential Impact on Investors - TipRanks
Q32 Bio Inc. posts first quarter 2026 financial results and issues corporate update - Traders Union
Q32 Bio Inc. 1Q 2026: Net loss $(7.61M), EPS $(0.54) — 10-Q Summary - TradingView
Q32 Bio Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Q32 Bio (QTTB) narrows Q1 2026 loss and funds runway into 1H 2028 - Stock Titan
Q32 Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update - PR Newswire
Wells Fargo initiated coverage on Q32 Bio with a new price target - Quantisnow
Q32 Bio Inc expected to post a loss of 68 cents a shareEarnings Preview - TradingView
Q32 Bio Gears Up to Report Q1 Earnings: What's in the Cards? - sharewise.com
Q32 Bio (QTTB) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Q32 Bio (NASDAQ:QTTB) Trading Down 3.8%What's Next? - MarketBeat
QTTB (Q32 Bio) posts massive Q4 2025 EPS beat, but shares drop 3.85 percent amid investor uncertainty.Market Buzz Alerts - newser.com
Q32 Bio Expands ATM Offering With New $75M Prospectus - The Globe and Mail
QTTB Price Today: Q32 Bio Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Q32 Bio files prospectus for up to $75 million at-the-market share offering - Investing.com UK
Q32 Bio Inc files additional prospectus to offer up to $75 million of common stock - marketscreener.com
Q32 Bio files $75M prospectus supplement after exhausting $14.2M ATM offering - TradingView
Q32 Bio (QTTB) Stock: Momentum Outlook | Q32 Bio Inc. delivers 515.8% EPS surprise topping estimatesRisk Event - Cổng thông tin điện tử tỉnh Lào Cai
Momentum Outlook | Q32 Bio Inc. delivers 515.8% EPS surprise topping estimatesPro Level Trade Signals - Cổng thông tin điện tử tỉnh Lào Cai
Q 32 Bio Inc Azioni (QTTB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.29%
0.81%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):